genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2016
Teva
Industry News
Teva Ends MPC Platform Collaboration with Mesoblast
Drug Discovery
Teva, AbCellera Launch Rare mAb Partnership
Industry News
Takeda, Teva to Launch Japan Venture in April
Industry News
Teva, Heptares Launch Up-to-$410M+ Migraine Alliance
A-Lists
Top 25 Biotech Companies of 2015
News
IBM Watson Health Opens HQ, Launches Partnerships
Industry News
Teva to Acquire Allergan’s Generics Business for $40.5B
Industry News
Teva to Acquire Auspex for $3.5B, Growing CNS Portfolio
Cancer
Ignyta Buys Four Cancer Compounds from Teva
A-Lists
Top 10 Clinical Trial Failures of 2014
1
2
3
4
...
11
Page 3 of 11
Scroll Up
Scroll Up
